We use cookies
BostonGene logo

Partnerships with leading pharma, academic medical centers and foundations

BostonGene’s AI-powered multiomics platform supports patient care, discovery and drug development
Johnson & Johnson
The partnership reflects BostonGene’s commitment to improving patient outcomes through innovative research and data-driven approaches.
Takeda
Takeda will leverage BostonGene's AI-powered multiomics platform in select early-stage clinical trials to enhance trial design, identify biomarker signatures for response and toxicity.
Ottimo Pharma
BostonGene Announces Collaboration with Ottimo Pharma to Optimize and Accelerate Development of First-in-Class PD-1/VEGFR2 Immuno-Oncology Therapy Using AI.
AstraZeneca
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
Partners
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, PA
AstraZeneca
Cambridge, UK
Brigham and Women's Hospital
Boston, MA
Dana Farber Cancer Institute
Boston, MA
Duke University
Durham, NC
Exigent Research
US
FibroFighters
Temecula, CA
Fujita Health University
Haneda, Japan
Hokkaido University Hospital
Sapporo, Japan
Johns Hopkins School of Medicine
Baltimore, MD
Johnson & Johnson
New Brunswick, NJ
Kyoto University
Kyoto City, Japan
LegoChem Biosciences
Daejeon, Korea
Mass General Hospital
Boston, MA
Mater Research
Australia